Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial.

ABSTRACT:

SUBMITTER: Kim HJ 

PROVIDER: S-EPMC6760543 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature